Post Merger Integration: The Most Critical – and Most Overlooked – Phase of Healthcare M&A

Peter Attwater, Managing Director

Health systems continue to pursue mergers, acquisitions, and member substitutions to expand access, enhance capabilities, and achieve scale that reduces administrative and fixed costs. While organizations devote substantial effort to evaluating potential partners, conducting due diligence, and preparing for Day 1, far fewer apply the same level of discipline to what happens afterward.

In our work across the country, we see a common pattern: once Day 1 arrives and the merger is formally executed, leadership attention often shifts back to immediate operational priorities. Day 1 becomes treated as the culmination of the deal, rather than the starting point. The real determinant of success, however, lies in the months that follow.

Post merger integration (PMI) is where the strategy, economics, and clinical goals of a transaction are either realized or quietly lost. Without a sustained and intentional approach, even the most well designed partnerships struggle to achieve the value envisioned at the outset.

Where Post Merger Integration Efforts Break Down

In hospital transactions, the sign to close period typically lasts 3-6 months. During this time, teams are energized, leaders are engaged, and workstreams move quickly. But after closing, the pace often slows just as the most complex issues begin to surface. Operational friction, duplicative cost structures, cultural disconnects, and clinical fragmentation rarely appear on Day 1 – they emerge over months or years when unresolved PMI priorities accumulate.

Two areas tend to create early challenges. First, Transition Services Agreements (TSAs), while essential, require ongoing monitoring to keep them as temporary bridges rather than long‑term operating dependencies. Their duration – often more than a year – can lull organizations into complacency, allowing cost, performance, and accountability issues to linger.

Second, EHR alignment often falls victim to competing IT demands. A unified digital platform is the backbone of revenue cycle integration, data sharing, clinical standardization, and quality reporting. Yet many systems delay the hard work of EHR consolidation, creating long-term obstacles to clinical and operational alignment.

Clinical Integration: The Heart of Deal Value

Many systems have already moved to a single EHR instance – an important milestone – but have not yet taken the next step into true clinical integration. That next step is where the strategic value of healthcare M&A is either unlocked or deferred.

Most transactions are motivated by aspirations to expand access, improve care delivery, optimize capacity, or enhance coordination across the continuum. Yet clinical integration is frequently treated as a later‑phase activity – something to be addressed once the dust from the merger has settled.

Clinical integration must be designed early and activated quickly. Decisions about how care will be distributed across the system – what moves out of an overextended flagship hospital or AMC, how lower-acuity services are repositioned, where specialty services should grow – cannot wait until year two. Without a clear roadmap, organizations risk preserving old patterns rather than creating the system-level benefits the transaction was intended to unlock.

Culture and Governance: The Underestimated Determinants of Success

Perhaps the most overlooked element of PMI is governance – particularly medical staff structures and bylaws. These decisions shape how clinicians engage, how quality and safety oversight is organized, and how the combined system begins to think and act as one. When governance remains fragmented, so does culture. Years after a merger, many organizations still hear staff identify themselves by their legacy system rather than the new enterprise they joined.

Integrating medical staff models, aligning committees and leadership structures, and establishing shared expectations for performance and accountability set the cultural foundation for the new organization. This work is challenging, but it is essential to create a unified system capable of delivering on the merger’s strategic goals.

A Discipline, Not a Phase

Successful PMI requires a long-term, disciplined approach. It calls for dedicated governance, clear accountability, a defined cadence for decision-making, and the willingness to maintain leadership focus well after the initial excitement of closing has passed. Integration is not a one-time effort – it is a multi-year journey that must be actively managed.

For health systems that are contemplating a transaction, or those that have recently completed one, now is the moment to focus on PMI. The success of the deal – and the ability to deliver meaningful operational, clinical, and financial value – depends on how effectively the organization navigates the period after Day 1.

BDC Advisors partners with leading health systems and AMCs across the country to design and execute post‑merger integration strategies that accelerate value realization, strengthen culture, streamline operations, and advance clinical excellence. If your organization is entering or emerging from a transaction, we would welcome a conversation about how to help make sure your PMI efforts deliver on the promise of your strategic vision.

---

If your organization is entering—or navigating—the post‑close phase of a merger or acquisition, we welcome a conversation about designing and executing a disciplined post‑merger integration strategy that delivers on clinical, operational, and financial goals. Contact Peter Attwater, Managing Director, BDC Advisors, at (786) 607-6189 or peter.attwater@bdcadvisors.com.